InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Humer Franz B, 董事. Director active across 3 companies, notably Allogene Therapeutics, Inc.. Aggregated, 8 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 10 June 2021. The latest transaction was filed on 5 December 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Franz B. Humer is a Board Member at Allogene Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Humer brings valuable expertise in the biopharmaceutical sector, which is essential for the company's development.